SHARE|| H7N9 Another Fauci-Funded BioWeapon

Did You Know That H7N9 is Under EUA?

Follow: Twitter | Instagram | Telegram | Gab | Facebook
Truth Lives Here: Rumble | Rokfin | Odysee | Brighteon | Bitchute | YouTube Websites: MaryamHenein.com | HoneyColony.com

If you have been following my work, you know about H7N9 circulating in Wuhan in 2020. If you missed the memo, this is yet another Fauci-funded bioweapon. Independent researcher John Cullen and I got into it during one of my latest episodes of Truth Lives Here. At that point, he told me that veterinarian Yoshihiro Kawaoka's H7N9 gained-of-functioned the virus—except nobody talks about that.

After a sharp decrease of influenza A(H7N9) virus in China in 2018, highly pathogenic H7N9 viruses re-emerged in 2019. All H7N9 viruses had four continuous essential amino acids at cleavage sites (i.e., KRKRTAR/G and KRKRIAR/G), suggesting high pathogenicity. So, according to very few, the ‘real’ virus in China was H7N9.

You can read about it in my previous Substack entries and on HoneyColony.com.

BARDA Just Ordered 4.8 Million Doses Of Avian Flu Vaccine

Bird Flu GOF Truth Hidden In Plain Sight?

Surprise! New Human Cases of Avian Flu Anticipated

Is The Avian Flu A Smokescreen?

In plain sight!

I read headlines about the latest flock or herd being annihilated daily. There are also unofficial HPAI maps and flu shots that are supposedly essential to protect against bird flu. And, of course, there is talk of new vaccines.

This week, there was an article titled U.S. Response to Avian Influenza, Echoes of Covid-19.

“Despite having a pandemic playbook in early 2020, the U.S. appeared flat-footed in its response to COVID-19, including inadequate testing and unavailable personal protective equipment. And throughout the pandemic, mixed messaging on masks and later vaccines set back public health efforts.

As H5N1 circulates, it seems that lessons from COVID-19 remain unlearned. Missteps are being made regarding testing, surveillance, transparency, and failure of communication and coordination throughout the healthcare system, which hurt the response to COVID-19.

“The World Health Organization,” according to NPR, “considers the virus a public health concern because of its potential to cause a pandemic.”

use beelady15 for 15 % OFF

Why Was H7N9 Therapeutics Recently Put Under EUA?

H7N9 was the predominant strain in China, and seemingly many died.

According to John Cullen, "The outbreak of COVID-19 in 2020 is reminiscent of the H7N9 outbreak in 2013, which poses a HUGE threat to human health. The proportion of fatal cases of H7N9 receiving antibiotics, antiviral drugs, and oxygen treatment was higher than that of COVID-19."

The surveillance continued for years.

And why would they remove the testing for H7N9 in January 2020?

H7N9 influenza was identified as a top health security concern before the National Security Council was disbanded in May 2018. Rear Admiral Luciana Borio, the NSC’s medical and biodefense preparedness director, stated in 2018 that “the threat of pandemic flu is the number one health security concern.”

Public health experts and lawmakers criticized the unit's elimination, warning that it would leave the country vulnerable to pandemics. In a letter to John Bolton, Congressmen Ami Bera (D-CA) and others expressed their deep concerns about the White House's recent actions to downgrade the importance of global health security.

It’s worth noting that while the NSC’s pandemic unit was disbanded, other agencies, such as the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), continued to work on pandemic preparedness and response.

In mid-2018, Fauci told Congress:

“When you have a respiratory virus that droplets and aerosol can spread and ... there’s a degree of morbidity associated with that, you can have a catastrophe. ... The one that we always talk about is the 1918 pandemic, which killed between 50 and 100 million people. ... Influenza first, or something like influenza, is the one that keeps me up at night.”

At the time, the White House was tracking an outbreak of H7N9, a new strain of the avian flu emerging in China.

The reorganization of the NSC under Bolton and what exactly happened to the pandemic response team have been disputed. The reorganization and streamlining of the National Security Council in the Trump era, specifically whether Bolton dismantled an office focused on pandemics, has emerged as a point of discussion and competing narratives.

Fast forward to July 2024. Why did the HHS Secretary amend section 564(b)(1)of the Federal Food, Drug, and Cosmetic Act to include influenza A viruses with pandemic potential?

"This amendment to the 2013 determination is being done as a part of HHS’ preparedness efforts, and no changes have been made in the avian flu public health risk determination," according to the McCullough Foundation.”

On April 19, 2013, according to section 564(b)(1)(C) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), former Secretary Sebelius determined that there is a significant potential for a public health emergency involving the avian influenza A (H7N9) virus to affect national security or the health and security of United States citizens living abroad.

On July 18, 2024, HHS Secretary Xavier Becerra wrote:

“I amend April 19, 2013, determination of a significant potential for a public health emergency involving the avian influenza A (H7N9) virus, according to section 564(b)(1)(C) of the FD&C Act, and at this moment determines that there is a significant potential for a public health emergency that has a considerable potential to affect national security or the health and security of United States citizens living abroad and that involves biological agents, namely pandemic influenza A viruses and influenza A viruses with pandemic potential. Because H7N9 is an influenza A virus with pandemic potential, the declaration issued on April 19, 2013, under section 564(b)(1) of the FD&C Act, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection of avian influenza A (H7N9) virus, and that is based on April 19, 2013, determination, remains in effect until that declaration is terminated by section 564 of the FD&C Act.”

SAM Vaccines, Nanotech, And H7N9

Barely anyone talks about the nano-forming on our planet as part of the transhumanist agenda. They are putting nano in the clouds, the soil, our animals, and us. And the mainstream is mum. They are going after our blood, breath, and heart. The global elitists want to meld man with machine.

Currently, the Self Assumling MrnA (SAM®) vaccine against H7N9 influenza is immunogenic in mice. Now, they are using an enzymatic, cell-free gene assembly technique to synthesize hemagglutinin (HA) and neuraminidase (NA) genes and their use to generate synthetic vaccine seeds in less than a week from discovering a new virus.

Of the new approaches, nucleic acid (plasmid DNA and mRNA) offers the most significant potential for speed. Similarly, testing of non-amplifying mRNA in preclinical animal models (mice, ferrets, and pigs) has indicated that two doses (80–250 µg) of vaccine are required to elicit protective responses. We have previously described the SAM vaccine platform.

This platform is based on a synthetic, self-amplifying mRNA delivered by a synthetic lipid nanoparticle (LNP).

The NIH paper demonstrates that a SAM vaccine encoding an influenza H1 HA antigen from the H1N1 virus was immunogenic in mice at low doses, eliciting antibody responses comparable to a licensed influenza vaccine. In addition, when they used the gene assembly and error correction technique for the rapid and accurate cell-free synthesis of the HA gene, they generated a SAM vaccine encoding an influenza H7 HA antigen from the H7N9 virus. The “vaccine” was ready for immunization eight days after the availability of the H7 gene sequence and 35 days after vaccination elicited mouse antibody titers associated with protecting humans from influenza.

Researchers say this indicates that combining gene synthesis and SAM vaccine technology could enable unprecedented speed and reliability of future vaccine responses to influenza pandemics.

They gauge that the combination of gene synthesis and the SAM vaccine technology could enable unprecedented speed and reliability of future vaccine responses to influenza pandemics.